Expert opinion on the use of cladribine tablets in clinical practice

BACKGROUND: Gaps in current product labels and a lack of detailed clinical guidelines leaves clinicians’ questions on the practical management of patients receiving cladribine tablets for the treatment of relapsing multiple sclerosis (MS) unanswered. We describe a consensus-based programme led by in...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ther Adv Neurol Disord
Autori principali: Sørensen, Per Soelberg, Centonze, Diego, Giovannoni, Gavin, Montalban, Xavier, Selchen, Daniel, Vermersch, Patrick, Wiendl, Heinz, Yamout, Bassem, Salloukh, Hashem, Rieckmann, Peter
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318823/
https://ncbi.nlm.nih.gov/pubmed/32636933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286420935019
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi